Quitline Use and Outcomes among Callers with and without Mental Health Conditions: A 7-Month Follow-Up Evaluation in Three States.
OBJECTIVE
To examine abstinence outcomes among tobacco users with and without a reported mental health condition (MHC) who enrolled in state tobacco quitline programs.


METHODS
Data were analyzed from a 7-month follow-up survey (response rate: 41% [3,132/7,459]) of three state-funded telephone quitline programs in the United States that assessed seven self-reported MHCs at quitline registration. We examined 30-day point prevalence tobacco quit rates for callers with any MHC versus none. Data were weighted to adjust for response bias and oversampling. Multivariable logistic regression was used to examine cessation outcomes.


RESULTS
Overall, 45.8% of respondents reported ≥ 1 MHC; 57.4% of those reporting a MHC reported ≥ 2 MHCs. The unadjusted quit rate for callers with any MHC was lower than for callers with no MHC (22.0% versus 31.0%, P < 0.001). After adjusting for demographics, nicotine dependence, and program engagement, callers reporting ≥ 1 MHC were less likely to be abstinent at follow-up (adjusted OR = 0.63, 95% CI = 0.51-0.78, P < 0.001).


CONCLUSIONS
More intensive or tailored quitline programs may need to be developed among callers with MHCs as their quit rates appear to be lower than callers without MHCs.
Alere Wellbeing, Inc., 999 Third Avenue, Suite 2000, Seattle, WA 98104, USA.
Katrina A
KA
Vickerman
Carter Consulting, Inc., Contractor to Office on Smoking and Health, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS F-79, Atlanta, GA 30341, USA.
Gillian L
GL
Schauer
Office on Smoking and Health, Centers for Disease Control and Prevention, 4770 Buford Highway, NE MS F-79, Atlanta, GA 30341, USA.
Ann M
AM
Malarcher
Office on Smoking and Health, Centers for Disease Control and Prevention, 4770 Buford Highway, NE MS F-79, Atlanta, GA 30341, USA.
Lei
L
Zhang
Biostatistics, Inc., 1738 Illehaw Drive, Sarasota, FL 34239, USA.
Paul
P
Mowery
Alere Wellbeing, Inc., 999 Third Avenue, Suite 2000, Seattle, WA 98104, USA.
Chelsea M
CM
Nash
D003376:Counseling / Q000706:statistics & numerical data*; D005260:Female; D005500:Follow-Up Studies; D006293:Health Promotion / Q000706:statistics & numerical data; D015277:Hotlines / Q000706:statistics & numerical data*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008396:Maryland / Q000453:epidemiology; D001523:Mental Disorders / Q000453:epidemiology* / Q000628:therapy; D008875:Middle Aged; D009329:Nebraska / Q000453:epidemiology; D009657:North Carolina / Q000453:epidemiology; D010353:Patient Education as Topic / Q000706:statistics & numerical data; D012907:Smoking / Q000453:epidemiology*; D016540:Smoking Cessation / Q000706:statistics & numerical data*; D000074606:Smoking Prevention; D061485:Tobacco Use Cessation Devices / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014600:Utilization Review